UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Evolution of multi‐drug resistant hepatitis B virus during sequential therapy

Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.703-712

2006

Volltextzugriff (PDF)

Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B

Hepatology (Baltimore, Md.), 2015-07, Vol.62 (1), p.118-128

2015

Volltextzugriff (PDF)

Genetic variation in STAT4 predicts response to interferon‐α therapy for hepatitis B e antigen‐positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2016-04, Vol.63 (4), p.1102-1111

2016

Volltextzugriff (PDF)

Mitogen‐activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial‐mesenchymal transition

Hepatology (Baltimore, Md.), 2015-12, Vol.62 (6), p.1804-1816

2015

Volltextzugriff (PDF)

Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor–induced epithelial‐mesenchymal transition

Hepatology (Baltimore, Md.), 2015-10, Vol.62 (4), p.1201-1214

2015

Volltextzugriff (PDF)

Allogeneic bone marrow–derived mesenchymal stromal cells for hepatitis B virus–related acute‐on‐chronic liver failure: A randomized controlled trial

Hepatology (Baltimore, Md.), 2017-07, Vol.66 (1), p.209-219

2017

Volltextzugriff (PDF)

CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2019-01, Vol.69 (1), p.143-159

2019

Volltextzugriff (PDF)

Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system

Hepatology (Baltimore, Md.), 2018-07, Vol.68 (1), p.141-154

2018

Volltextzugriff (PDF)

Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

Hepatology (Baltimore, Md.), 2009-08, Vol.50 (2), p.490-499

2009

Volltextzugriff (PDF)

Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression

Hepatology (Baltimore, Md.), 2015-05, Vol.61 (5), p.1603

2015

Volltextzugriff (PDF)

Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients

Hepatology (Baltimore, Md.), 2014-04, Vol.59 (4), p.1293-1302

2014

Volltextzugriff (PDF)

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes

Hepatology (Baltimore, Md.), 2011-09, Vol.54 (3), p.820-828

2011

Volltextzugriff (PDF)

Autophagy suppresses tumorigenesis of hepatitis B virus‐associated hepatocellular carcinoma through degradation of microRNA‐224

Hepatology (Baltimore, Md.), 2014-02, Vol.59 (2), p.505-517

2014

Volltextzugriff (PDF)

Hepatic Small Ubiquitin‐Related Modifier (SUMO)–Specific Protease 2 Controls Systemic Metabolism Through SUMOylation‐Dependent Regulation of Liver–Adipose Tissue Crosstalk

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.1864-1883

2021

Volltextzugriff (PDF)

CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenase

Hepatology (Baltimore, Md.), 2022-01, Vol.75 (1), p.28-42

2022

Volltextzugriff (PDF)

qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis

Hepatology (Baltimore, Md.), 2020-06, Vol.71 (6), p.1953-1966

2020

Volltextzugriff (PDF)

MicroRNA‐10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4‐Mediated epithelial‐mesenchymal transition and adhesion in hepatoma cells

Hepatology (Baltimore, Md.), 2013-02, Vol.57 (2), p.667-677

2013

Volltextzugriff (PDF)

Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2016-03, Vol.63 (3), p.850-863

2016

Volltextzugriff (PDF)

MicroRNAs‐372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B

Hepatology (Baltimore, Md.), 2011-09, Vol.54 (3), p.808-819

2011

Volltextzugriff (PDF)

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow‐up

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2135-2142

2013

Volltextzugriff (PDF)

Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2016-09, Vol.64 (3), p.720-731

2016

Volltextzugriff (PDF)

Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis

Hepatology (Baltimore, Md.), 2024-03, Vol.79 (3), p.690-703

2024

Volltextzugriff (PDF)

Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia

Hepatology (Baltimore, Md.), 2019-11, Vol.70 (5), p.1658-1673

2019

Volltextzugriff (PDF)

Dual role for inositol‐requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet‐induced obesity in mice

Hepatology (Baltimore, Md.), 2018-08, Vol.68 (2), p.533-546

2018

Volltextzugriff (PDF)

Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity

Hepatology (Baltimore, Md.), 2020-08, Vol.72 (2), p.518-534

2020

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals

Zeitschrift / SerieHepatology

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Gastroenterology & Hepatology
(46)
Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Hepatology
(33)
Male
(31)
Female
(25)
Middle Aged
(21)
Animals
(20)
Adult
(17)
Mice
(16)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Gastroenterology. Liver. Pancreas. Abdomen
(12)
Liver Cancer
(12)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(11)
Carcinoma, Hepatocellular - Pathology
(10)
Liver Neoplasms - Metabolism
(10)
Liver Neoplasms - Pathology
(10)
Tumors
(10)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(50)
Wiley Online Library Full Collection 2018
(50)
EZB Electronic Journals Library
(50)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(50)
Ingenta
(50)

Menü

Weitere Dienste

Einstellungen

Evolution of multi‐drug resistant hepatitis B virus during sequential therapy

Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B

Genetic variation in STAT4 predicts response to interferon‐α therapy for hepatitis B e antigen‐positive chronic hepatitis B

Mitogen‐activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial‐mesenchymal transition

Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor–induced epithelial‐mesenchymal transition

Allogeneic bone marrow–derived mesenchymal stromal cells for hepatitis B virus–related acute‐on‐chronic liver failure: A randomized controlled trial

CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma

Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system

Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression

Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes

Autophagy suppresses tumorigenesis of hepatitis B virus‐associated hepatocellular carcinoma through degradation of microRNA‐224

Hepatic Small Ubiquitin‐Related Modifier (SUMO)–Specific Protease 2 Controls Systemic Metabolism Through SUMOylation‐Dependent Regulation of Liver–Adipose Tissue Crosstalk

CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenase

qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis

MicroRNA‐10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4‐Mediated epithelial‐mesenchymal transition and adhesion in hepatoma cells

Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma

MicroRNAs‐372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow‐up

Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma

Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis

Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia

Dual role for inositol‐requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet‐induced obesity in mice

Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity

Aktive Filter

Suchergebnisse filtern